Yuping Wu
#185,305
Most Influential Person Now
Yuping Wu's AcademicInfluence.com Rankings
Yuping Wubiology Degrees
Biology
#15571
World Rank
#19586
Historical Rank
Microbiology
#1057
World Rank
#1181
Historical Rank
Biochemistry
#2736
World Rank
#2923
Historical Rank
Download Badge
Biology
Yuping Wu's Degrees
- PhD Biochemistry University of California, Berkeley
- Bachelors Biology Peking University
Similar Degrees You Can Earn
Why Is Yuping Wu Influential?
(Suggest an Edit or Addition)Yuping Wu's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease (2011) (4016)
- Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis (2013) (3174)
- Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. (2013) (2343)
- Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk (2016) (1136)
- Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease (2015) (704)
- Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. (2014) (514)
- Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. (2014) (459)
- γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. (2014) (383)
- Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors (2017) (338)
- Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks (2013) (299)
- A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors (2020) (263)
- Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. (2015) (246)
- Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women (2018) (245)
- Choline Diet and Its Gut Microbe–Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload–Induced Heart Failure (2016) (245)
- Intestinal Microbiota‐Generated Metabolite Trimethylamine‐N‐Oxide and 5‐Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE‐Like Patient Cohort (2016) (185)
- Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden. (2016) (176)
- L-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans (2018) (171)
- Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus. (2017) (161)
- Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk (2012) (154)
- Trimethylamine N‐Oxide and Mortality Risk in Patients With Peripheral Artery Disease (2016) (126)
- Prognostic Role of Pulmonary Arterial Capacitance in Advanced Heart Failure (2012) (117)
- Prognostic Role of Serum Chloride Levels in Acute Decompensated Heart Failure. (2015) (115)
- Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk. (2018) (104)
- Function and Distribution of Apolipoprotein A1 in the Artery Wall Are Markedly Distinct From Those in Plasma (2013) (103)
- Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease. (2011) (92)
- The Heart Failure Overweight/Obesity Survival Paradox: The Missing Sex Link. (2015) (83)
- Diminished Antioxidant Activity of High‐Density Lipoprotein–Associated Proteins in Chronic Kidney Disease (2013) (75)
- Cystatin C Identifies Patients With Stable Chronic Heart Failure at Increased Risk for Adverse Cardiovascular Events (2012) (71)
- Single exhaled breath metabolomic analysis identifies unique breathprint in patients with acute decompensated heart failure. (2013) (71)
- Diminished Antioxidant Activity of High-Density Lipoprotein–Associated Proteins in Systolic Heart Failure (2011) (67)
- Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes. (2019) (67)
- Clinical and Genetic Association of Serum Ceruloplasmin With Cardiovascular Risk (2012) (64)
- Myeloperoxidase Mediates Postischemic Arrhythmogenic Ventricular Remodeling (2017) (52)
- Biomarkers of Cardiovascular Disease (2017) (52)
- Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart Failure (2015) (50)
- Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure. (2016) (50)
- Increased mortality with elevated plasma endothelin‐1 in acute heart failure: an ASCEND‐HF biomarker substudy (2016) (49)
- Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis (2018) (39)
- Prognostic value of elevated serum ceruloplasmin levels in patients with heart failure. (2014) (39)
- Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure. (2015) (38)
- Immunoglobulins Against Tyrosine-Nitrated Epitopes in Coronary Artery Disease (2012) (37)
- Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure (2016) (33)
- Subclinical Myocardial Necrosis and Cardiovascular Risk in Stable Patients Undergoing Elective Cardiac Evaluation (2010) (30)
- Prognostic Value of Estimated Functional Capacity Incremental to Cardiac Biomarkers in Stable Cardiac Patients (2014) (28)
- Prognostic role of cardiac power index in ambulatory patients with advanced heart failure (2015) (27)
- High‐density lipoprotein‐associated paraoxonase‐1 activity for prediction of adverse outcomes in outpatients with chronic heart failure (2017) (24)
- Genetic, dietary, and sex-specific regulation of hepatic ceramides and the relationship between hepatic ceramides and IR[S] (2018) (21)
- Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk Prospective Population Study. (2021) (20)
- Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD. (2014) (20)
- Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). (2015) (19)
- Comprehensive Peroxidase-Based Hematologic Profiling for the Prediction of 1-Year Myocardial Infarction and Death (2010) (18)
- Genetic markers of IgG influence the outcome of infection with hepatitis C virus. (2008) (17)
- Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2. (2008) (17)
- Detectable Subclinical Myocardial Necrosis Is Associated With Cardiovascular Risk in Stable Patients With Diabetes (2013) (14)
- Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status. (2013) (13)
- Relation of Red Cell Distribution Width to Left Ventricular End-Diastolic Pressure and Mortality in Patients With and Without Heart Failure. (2017) (11)
- Usefulness of Relative Hypochromia in Risk Stratification for Nonanemic Patients With Chronic Heart Failure. (2016) (10)
- Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Sub-Study. (2021) (7)
- Predicting long‐term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status Index (2017) (6)
- Prognostic value of subclinical myocardial necrosis using high-sensitivity cardiac troponin T in patients with prediabetes (2021) (5)
- PROGNOSTIC VALUE OF ELEVATED LEVELS OF INTESTINAL MICROFLORA-GENERATED METABOLITE TRIMETHYLAMINE N-OXIDE IN PATIENTS WITH HEART FAILURE: THE GUT HYPOTHESIS REVISITED (2013) (5)
- The artificial sweetener erythritol and cardiovascular event risk (2023) (4)
- GUT FLORA METABOLITE TRIMETHYLAMINE N-OXIDE PREDICTS INCIDENT CARDIOVASCULAR RISKS IN BOTH STABLE NON-DIABETICS AND DIABETIC SUBJECTS (2013) (4)
- PSS147 – Uric Acid Oxidation as a Biomarker of Cardiovascular Disease (2013) (4)
- Elevated Plasma Homocysteine Identifies Patients With Chronic Heart Failure at Increased Cardiovascular Risk (2012) (3)
- ELEVATED PLASMA TRIMETHYLAMINE-N-OXIDE IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (2015) (2)
- HIGHER PLASMA TRIMETHYLAMINE-N-OXIDE IS ASSOCIATED WITH GREATER ATHEROSCLEROTIC BURDEN QUANTIFIED BY THE SYNTAX SCORE (2015) (2)
- Prognostic Importance of Serial Evaluation of Blood Urea Nitrogen in Ambulatory Patients with Chronic Systolic Heart Failure and Preserved Renal Function (2011) (2)
- A High Performance Biomarker Detection Method for Exhaled Breath Mass Spectrometry Data (2014) (1)
- CROTONOBETAINE IS A PROATHEROGENIC GUT MICROBIOTA METABOLITE OF L-CARNITINE (2019) (1)
- THE SYSTEMIC INFLAMMATION-BASED GLASGOW PROGNOSTIC SCORE AND CARDIOVASCULAR RISK IN STABLE PATIENTS UNDERGOING ELECTIVE CARDIAC EVALUATION (2015) (1)
- Reply: Concerning the Role of Gender Difference in Obesity Paradox in Patients With Heart Failure. (2016) (1)
- Abstract 18791: Serum Ceruloplasmin Independently Predicts Cardiovascular Risk in Stable Cardiac Patients (2010) (1)
- MYELOPEROXIDASE PREDICTS FUTURE CARDIOVASCULAR RISK IN STABLE CARDIAC PATIENTS WITH PREDIABETES (2011) (0)
- Vascular Markers, Emerging Biomarkers in Heart Failure with Preserved Ejection Fraction (2014) (0)
- Abstract 19: Prognostic Value of Plasma Choline and Betaine Depend on the Intestinal Microflora-generated Metabolite Trimethylamine N-oxide (2013) (0)
- Cangrelor Use in the Treatment of Left Ventricular Assist Device Thrombosis : A Case Report (0)
- Serum Arylesterase Activity Levels Provide Stronger Prognostic Value Than Serum Paraoxonase Activity Levels in Patients with Heart Failure (2011) (0)
- Genetic, dietary, and sex-specific regulation of hepatic ceramides and relationship between hepatic ceramides and insulin resistance (2018) (0)
- C3a, C4a, and C5a Complement Anaphylatoxins Are Paradoxically Decreased in Acute and Chronic Heart Failure (2020) (0)
- DIMINISHED PAROXONASE-1 ACTIVITY, A MARKER OF DYSFUNCTIONAL HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, RECLASSIFIES STABLE CARDIAC PATIENTS AT HIGHER RISK FOR DEVELOPING MAJOR ADVERSE CARDIAC EVENTS (2010) (0)
- Abstract 17568: Subclinical Myocardial Dysfunction as Detected by Elevated Natriuretic Peptide Levels Confer Increased Long-Term Risk in Patients Without Clinical Diagnosis of Heart Failure and Renal Dysfunction (2017) (0)
- Clinical Investigations Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction, and Adverse Clinical Outcomes in Chronic Systolic Heart Failure (2015) (0)
- Prediction of Future Cardiovascular Risk by Detecting Subclinical Myocardial Necrosis in Stable Patients with Diabetes Mellitus (2011) (0)
- Abstract 12550: Persistent Relative Hypochromia is Associated With Adverse Outcomes in Non-anemic Patients With Heart Failure (2015) (0)
- ELEVATED PLASMA MYELOPEROXIDASE AS INDICATOR FOR VULNERABLE PLAQUE IN STABLE PATIENTS WITH SIGNIFICANT ATHEROSCLEROTIC BURDEN (2010) (0)
- Elevated Cystatin C Predicts Long-Term Adverse Cardiac Events in Patients with Heart Failure Independent of Natriuretic Peptide Levels and Creatinine Clearance (2011) (0)
- Anti-Cyclic Citrullinated Peptide Antibodies are Not Elevated in a Heart Failure Population without Rheumatoid Arthritis (2012) (0)
- Abstract 13809: Serial Paraoxonase-1-associated Serum Arylesterase Activity and Outcomes in Ambulatory Patients With Heart Failure (2015) (0)
- VITAMIN D LEVELS HAVE POOR PROGNOSTIC UTILITY AS A PREDICTOR OF OUTCOMES IN A LARGE STABLE CARDIOVASCULAR COHORT (2012) (0)
- Prognostic Role of Serum Chloride Levels in Acute Decompensated Heart Failure (2015) (0)
- Prognostic Importance of Serial Evaluation of Blood Urea Nitrogen in Ambulatory Patients With Chronic Systolic Heart Failure (2010) (0)
- Coronary Heart Disease Immunoglobulins Against Tyrosine-Nitrated Epitopes in Coronary Artery Disease (2012) (0)
- Erratum: Prognostic role of serum chloride levels in acute decompensated heart failure (Journal of the American College of Cardiology (2015) 66 (659-666)) (2015) (0)
- Impaired HDL Function Predicts Subclinical Myocardial Necrosis in Patients at Risk of Developing Heart Failure (2011) (0)
- INCREMENTAL RISK STRATIFICATION IN STABLE PATIENTS UNDERGOING ELECTIVE CARDIAC CATHETERIZATION WITH CARDIAC BIOMARKER SCORE (CBS) (2010) (0)
- Abstract 16237: Predicting Long-term Prognosis in Stable Peripheral Artery Disease With Baseline Functional Capacity Estimated by the Duke Activity Status Index (2015) (0)
- ASSOCIATIONS BETWEEN LONG CHAIN CERAMIDE LEVELS AND HEART FAILURE PHENOTYPES IN STABLE CARDIAC PATIENTS (2018) (0)
- PROGNOSTIC SIGNIFICANCE OF DETECTABLE HIGH-SENSITIVITY CARDIAC TROPONIN T IN STABLE CARDIAC PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOGRAPHY (2015) (0)
- Abstract 18732: Elevated Apolipoprotein A2 Adjusted for High-Density Lipoprotein is Associated with Atherosclerotic Burden and Progression in Stable Cardiac Patients (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Yuping Wu?
Yuping Wu is affiliated with the following schools:
